ENDRA Life Sciences (NDRA) Misses Q1 EPS by 3c

ENDRA Life Sciences (NASDAQ: NDRA) reported Q1 EPS of ($0.93), $0.03 worse than the analyst estimate of ($0.90).

For earnings history and earnings-related data on ENDRA Life Sciences (NDRA) click here.

You May Also Be Interested In

• Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
• Oregon Pacific Bancorp (ORPB) Tops Q2 EPS by 38c
• TPU-As-A-Service could boost Google’s 2028 profit by over 15%: Barclays